- Home
- LTRX vs BIOA Comparison
LTRX vs BIOA Comparison
Compare LTRX & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTRX
- BIOA
- Stock Information
- Founded
- LTRX 1989
- BIOA 2015
- Country
- LTRX United States
- BIOA United States
- Employees
- LTRX N/A
- BIOA N/A
- Industry
- LTRX Computer Communications Equipment
- BIOA Biotechnology: Pharmaceutical Preparations
- Sector
- LTRX Telecommunications
- BIOA Health Care
- Exchange
- LTRX Nasdaq
- BIOA Nasdaq
- Market Cap
- LTRX 183.6M
- BIOA 155.2M
- IPO Year
- LTRX 2000
- BIOA 2024
- Fundamental
- Price
- LTRX $4.45
- BIOA $4.80
- Analyst Decision
- LTRX Strong Buy
- BIOA Hold
- Analyst Count
- LTRX 4
- BIOA 4
- Target Price
- LTRX $4.38
- BIOA $5.67
- AVG Volume (30 Days)
- LTRX 734.4K
- BIOA 166.8K
- Earning Date
- LTRX 11-06-2025
- BIOA 11-06-2025
- Dividend Yield
- LTRX N/A
- BIOA N/A
- EPS Growth
- LTRX N/A
- BIOA N/A
- EPS
- LTRX N/A
- BIOA N/A
- Revenue
- LTRX $122,923,000.00
- BIOA $3,863,000.00
- Revenue This Year
- LTRX $4.81
- BIOA N/A
- Revenue Next Year
- LTRX $11.85
- BIOA N/A
- P/E Ratio
- LTRX N/A
- BIOA N/A
- Revenue Growth
- LTRX N/A
- BIOA N/A
- 52 Week Low
- LTRX $1.91
- BIOA $2.88
- 52 Week High
- LTRX $5.06
- BIOA $26.62
- Technical
- Relative Strength Index (RSI)
- LTRX 60.39
- BIOA 53.70
- Support Level
- LTRX $4.43
- BIOA $4.55
- Resistance Level
- LTRX $4.87
- BIOA $5.09
- Average True Range (ATR)
- LTRX 0.32
- BIOA 0.21
- MACD
- LTRX 0.00
- BIOA 0.01
- Stochastic Oscillator
- LTRX 63.03
- BIOA 55.88
About LTRX Lantronix Inc.
Lantronix Inc is a networking company. It provides secure data access and management solutions for the Internet of Things (IoT) and information technology assets. It organizes its products and solutions into three product lines: Embedded IoT Solutions, IoT Systems Solutions, and Software and Services. The IoT System Solutions segment is the key revenue driver for the company. The company serves a diverse range of markets including healthcare, industrial, security, energy, transportation, and government networking. Its primary geographic markets are the Americas, Europe, the Middle East and Africa, and Asia Pacific Japan. The Americas contribute the vast majority of total revenue.
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.